Form 4: Humana Chief Legal Officer Reports Stock Transactions
SEC Form 4 Filing
Humana's Chief Legal Officer, Joseph C. Ventura, reported multiple transactions involving company stock and derivative securities on December 15, 2024.
Summary
- Joseph C. Ventura, Chief Legal Officer of Humana Inc., filed a Form 4 detailing changes in his beneficial ownership of company securities.
- The transactions occurred on December 15, 2024, and include the disposition of shares to cover tax liabilities related to vested restricted stock units.
- Ventura also acquired shares through the vesting of restricted stock units and the exercise of options.
- The reported transactions involve both common stock and derivative securities, such as stock options and restricted stock units.
- The form details the number of shares and derivative securities held by Ventura both directly and indirectly.
Sentiment
Score: 5
Explanation: The document is a routine filing of stock transactions by an executive, which is neither positive nor negative for the company's performance. It is a neutral event.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common practice in publicly traded companies. It provides transparency into the executive's holdings and transactions.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
- The transactions reported are typical for executives who receive stock-based compensation, including stock options and restricted stock units.
- The vesting schedules and tax liability dispositions are consistent with common compensation practices.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they are routine and do not indicate a change in the company's fundamentals.
- The transactions are part of the executive's compensation package and do not affect the company's operations.
Key Dates
| Date | Description |
|---|---|
| 02/24/2020 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/24/21 to 2/24/23. |
| 02/22/2021 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/22/22 to 2/22/24. |
| 02/21/2022 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/21/23 to 2/21/25. Restricted stock units granted, 33% vesting on 12/15/22, 12/15/23, and 12/15/24. |
| 02/24/2023 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/24/24 to 2/24/26. Restricted stock units granted, 33% vesting on 12/15/23, 12/15/24, and 12/15/25. |
| 02/21/2024 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/21/25 to 2/21/27. |
| 12/15/2024 | Date of reported stock transactions, including vesting of restricted stock units and disposition of shares for tax liabilities. |
| 12/17/2024 | Date of signature of the Form 4 filing. |
Keywords
Humana, Stock Transactions, Form 4, Beneficial Ownership, Derivative Securities, Stock Options, Restricted Stock Units, Chief Legal Officer, Equity Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.